(12-03-10) Updated systematic review and meta-analysis of the effects of n?3 long-chain polyunsaturated fatty acids on depressed mood1,2,3

Katherine M Appleton, Peter J Rogers and Andrew R Ness

1 From the School of Psychology Queen's University Belfast Belfast United Kingdom (KMA); the Department of Experimental Psychology University of Bristol Bristol United Kingdom (PJR);the Department of OralDental Science Bristol United Kingdom (ARN).
2 Supported by Queen's University, Belfast, United Kingdom, and the University of Bristol, Bristol, United Kingdom.
3 Address correspondence to KM Appleton, School of Psychology, Queen's University, Belfast, 18-30 Malone Road, Belfast, BT9 5BP, United Kingdom. E-mail: [email protected] .
Background: The debate over a role for n?3 long-chain polyunsaturated fatty acids (n?3 PUFAs) in depressed mood continues.
Objective: The objective was to update a previous systematic review and meta-analysis of published randomized controlled trials investigating the effects of n?3 PUFAs on depressed mood and to explore potential sources of heterogeneity.
Design: Eight databases were searched for trials that randomly assigned participants to receive n?3 PUFAs/fish, measured depressed mood, used human participants, and included a comparison group up to April 2009.
Results: Thirty-five randomized controlled trials were identified; 17 were not included in the previous review. The pooled standardized difference in mean outcome of the 29 trials that provided data to allow pooling (fixed-effects model) was 0.10 SD (95% CI: 0.02, 0.17) in those who received n?3 PUFAs compared with placebo, with strong evidence of heterogeneity (I2 = 65%, P < 0.01). The presence of funnel plot asymmetry suggested that publication bias was a likely source of this heterogeneity. Depressive symptom severity and participant diagnosis also explained some of the observed heterogeneity. Greater effects of n?3 PUFAs were found in individuals with more-severe depressive symptoms. In trials that enrolled individuals with a diagnosed depressive disorder, the combined mean difference was 0.41 (95% CI: 0.26, 0.55), although evidence of heterogeneity was also found (I2 = 71%). In trials that enrolled individuals without a depressive diagnosis, no beneficial effects of n?3 PUFAs were found (largest combined mean difference: 0.22; 95% CI: ?0.01, 0.44; I2 = 0%).
Conclusions: Trial evidence of the effects of n?3 PUFAs on depressed mood has increased but remains difficult to summarize because of considerable heterogeneity. The evidence available provides some support of a benefit of n?3 PUFAs in individuals with diagnosed depressive illness but no evidence of any benefit in individuals without a diagnosis of depressive illness.

Source: Am J Clin Nutr 91: 757-770, 2010

News

---

In evidenza

"L'informazione presente nel sito serve a migliorare, e non a sostituire, il rapporto medico-paziente."

Per coloro che hanno problemi di salute si consiglia di consultare sempre il proprio medico curante.